Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Epilepsy Res ; 31(1): 29-38, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9696298

RESUMO

Murine neocortical tissue blocks 450 microm in diameter displayed prolonged epileptiform bursts when exposed to magnesium-free medium in vitro; no evidence was found for a correlation between the ability to generate paroxysmal bursts and barrels, the specialized cortical modules or 'columns' found in rodent primary sensorimotor cortex. While previous reports suggested that preferential locations for the generation of epileptiform bursts exist within the six-layered structure of the neocortex, we find that cortical sections only containing either the supragranular or infragranular layers and an estimated 2000 neurones are capable of displaying epileptiform bursting. The subdivided blocks are markedly more sensitive to the inhibitory effects of bath-applied adenosine (100 microM) than intact blocks from the same animal. A similar enhancement of adenosine sensitivity is seen when the tissue is superfused with hypotonic ACSF (a model for injury-induced brain swelling), which by itself increases excitability. The increase in sensitivity to adenosine is a transient effect and may be related to its role as acute neuroprotective agent.


Assuntos
Epilepsia/fisiopatologia , Neocórtex/fisiologia , Adenosina/farmacologia , Animais , Técnicas de Cultura/métodos , Cultura em Câmaras de Difusão , Relação Dose-Resposta a Droga , Potenciais Evocados/efeitos dos fármacos , Potenciais Evocados/fisiologia , Feminino , Deficiência de Magnésio , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Modelos Biológicos , Concentração Osmolar , Perfusão , Córtex Somatossensorial/citologia , Córtex Somatossensorial/efeitos dos fármacos , Córtex Somatossensorial/fisiologia
2.
Exp Neurol ; 152(2): 177-87, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9710516

RESUMO

Fast optical recordings by means of laser scanning microscopy in conjunction with a voltage-sensitive dye (RH 414) were performed to monitor the spatio-temporal spread of neuronal activity in CA3/CA4-lesioned C57BL6 mouse hippocampal slices prepared approximately 3 months after intracerebroventricular kainic acid (KA) injection. The aim of our study was to assess the effects of a circumscribed neuronal loss on the propagation of electrical activity along the trisynaptic hippocampal circuit. Both in physiological bathing solution and in bicuculline (10 microM), hilar stimulation failed to activate the downstream pathway, so that, under these conditions, the chronically disinhibited CA1 region appeared to be effectively isolated from burst activity arising upstream; however, epileptiform discharges evoked in zero Mg2+ solution were reliably transmitted from the dentate gyrus to the CA1 region. That these bursts were indeed spreading across the lesion, and not along newly formed connections (e.g., between dentate gyrus and CA1), was confirmed by acute transection experiments of the Schaffer collateral/commissural pathway, which completely abolished translesional burst propagation. The fact that the surviving CA3-CA1 connections are unable to trigger epileptiform bursts after suppression of GABAergic inhibition suggests that the lesioned region might serve as a filter that shields hyperexcitable CA1 neurons from epileptic activity arising upstream, in particular from chronically disinhibited granule cells of the dentate gyrus. An impaired GABAergic inhibition will thus only have minor facilitating effects on seizure propagation in the hippocampus of CA3-lesioned animals.


Assuntos
Hipocampo/citologia , Animais , Bicuculina/farmacologia , Estimulação Elétrica , Feminino , Corantes Fluorescentes , Antagonistas GABAérgicos/farmacologia , Técnicas In Vitro , Ácido Caínico/toxicidade , Potenciais da Membrana/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Microscopia Confocal , Inibição Neural , Neuroglia/fisiologia , Neurônios/fisiologia , Compostos de Piridínio , Fatores de Tempo
3.
Exp Brain Res ; 113(2): 303-10, 1997 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9063716

RESUMO

Despite its potent proconvulsant effects in vitro, the adenosine A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) does not induce seizures when administered in vivo. This contrasts with the effects of less selective adenosine antagonists such as theophylline or cyclopentlytheophylline, and led us to reexamine the nature of DPCPX-induced epileptiform activity. In the present study, we report that proconvulsant effects of bath-applied DPCPX in rat hippocampal slices are only observed after a preceding stimulus such as NMDA receptor activation or brief tetanic stimulation. While this may be due to the absence of a basal "purinergic tone", the relatively high interstitial concentrations of adenosine present in the slice suggest that access of the drug to A1 receptors may instead be prevented by tightly coupled endogenous adenosine, with the ternary adenosine-A1 receptor-G protein complex stabilised in the high-affinity conformation by a coupling cofactor. This implies that a substantial percentage of adenosine A1 receptors are inactive under physiological conditions, but that access of adenosine A1 receptor antagonists may be facilitated under pathological conditions. Once induced, DPCPX-evoked spiking persists for long periods of time. A "kindling" effect of A1 receptor blockade is unlikely, since persistent spiking is not usually observed with less selective A1 antagonists even after prolonged application. Alternatively, endogenous adenosine released during increased neuronal activity may activate A2 receptors during selective A1 blockade. The most important factor determining the duration of DPCPX-induced spiking, however, may be a persistence of the drug in the tissue and subsequent access to the A1 receptor via a membrane-delineated pathway, since DPCPX-induced spiking could be shown to decrease markedly after a transient superfusion of theophylline. This hypothesis, which implies that the apparent affinity of adenosine antagonists for the A1 receptor is in part a function of their membrane partitioning coefficient, is supported by a close correlation between alkylxanthine logP values obtained from the literature and their Ki value at A1 receptors, but not at the enzyme phosphodiesterase, whose xanthine binding site is presented to the cytosol. The implications for the therapeutic value of purinergic drugs are discussed.


Assuntos
Epilepsia/induzido quimicamente , Hipocampo/efeitos dos fármacos , Antagonistas de Receptores Purinérgicos P1 , Xantinas/farmacologia , Animais , Relação Dose-Resposta a Droga , Técnicas In Vitro , Masculino , Ratos , Ratos Wistar
4.
Eur J Neurosci ; 7(12): 2450-7, 1995 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-8845950

RESUMO

Fast cyclic voltammetry was used to assess the effects of chronic oral haloperidol treatment (0.7 mg/kg/day for 21 days) on the sensitivity of dopamine autoreceptors in the rat nucleus accumbens both in vivo and in vitro. Evoked dopamine overflow was significantly reduced after chronic haloperidol treatment, but the sensitivity of dopamine overflow to sulpiride, an antagonist at release-inhibiting dopamine autoreceptors, and quinpirole, an agonist at these receptors, was unchanged. The estimated EC50 values for quinpirole and sulpiride (52 and 60 nM respectively) obtained in vitro and the receptor distribution profiles published in the literature suggest that the autoreceptors involved in this modulation are mainly of the D3 subtype. The finding that the reduced dopamine overflow in the nucleus accumbens observed after chronic treatment with a classical neuroleptic is not due to dopamine autoreceptor supersensitivity may therefore be the first functional evidence for unchanged autoreceptor activity in the nucleus accumbens, supporting biochemical findings of a lack of D3 autoreceptor up-regulation after chronic haloperidol treatment. It lends further support to the assumption that the long-term changes occurring during chronic neuroleptic treatment may not lie at the level of presynaptic dopamine receptor regulation.


Assuntos
Autorreceptores/efeitos dos fármacos , Dopamina/metabolismo , Haloperidol/farmacologia , Núcleo Accumbens/efeitos dos fármacos , Animais , Agonistas de Dopamina/farmacologia , Relação Dose-Resposta a Droga , Ergolinas/farmacologia , Masculino , Quimpirol , Ratos , Sulpirida/farmacologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...